Results 221 to 230 of about 27,323 (239)

Antifungal Susceptibility Testing and Therapy

2009
The development of new therapies to treat fatal diseases is creating an increasing number of patients who have predisposing factors for infections by opportunistic yeasts. The rise in the prevalence of fungal infections has been the drive to develop and license several new antifungal agents such as new formulations of polyenes, new triazole agents and ...
Manuel Cuenca-Estrella, Juan Luis Rodriguez-Tudela   +1 more
openaire   +1 more source

Susceptibility Testing Methods of Antifungal Agents

2005
Several methods for testing antifungal susceptibility are currently utilized. Minimum inhibitory concentrations can be tested using standardized noncommercial or commercial tests. Fungicidal testing includes either in vitro methods, such as time-kill or minimum fungicidal testing methods, or animal models.
openaire   +2 more sources

Antifungal drug susceptibility testing

Medical Mycology, 1994
J, Van Cutsem, H, Kurata, H, Matsuoka, Y, Mikami, M A, Pfaller, G M, Scalarone, M G, Rinaldi   +6 more
openaire   +2 more sources

Antifungal susceptibility testing with dermatophytes.

Mycoses, 1992
The determination of the in vitro activity of antimycotics against dermatophytes has for long been considered as irrelevant from a practical point of view. Recently, however, this approach has been questioned. Various different tests such as agar diffusion test, agar dilution test and broth dilution test can be used for the determination of minimum ...
A, Georgii, H C, Korting
openaire   +1 more source

Etest for antifungal susceptibility testing of yeasts

Diagnostic Microbiology and Infectious Disease, 1994
Comparison [+/- 1 dilution between minimum inhibitory concentrations (MICs)] of fluconazole and flucytosine Etest MICs of 10 candidate quality control yeast isolates and 78 clinical isolates demonstrated good agreement (> or = 90%) with the reference method (National Committee for Clinical Laboratory Standards document M27-P).
openaire   +2 more sources

Antifungal susceptibility testing

2004
During the past few decades, advances in medical technology and the development of new diagnostic and treatment approaches have increased the life expectancy of critically ill patients. The global human immunodeficiency virus (HIV) epidemic has resultedin an increase in severely ill immunocompromised hospitalized patients, accompanied by more reports ...
openaire   +1 more source

ANTIFUNGAL SUSCEPTIBILITY TESTING

Infectious Disease Clinics of North America, 2001
Michael A. Pfaller, Wen Liang Yu
openaire   +1 more source

Standardization of antifungal susceptibility testing

Medical Mycology, 1992
J N, Galgiani, M G, Rinaldi, A M, Polak, M A, Pfaller   +3 more
openaire   +2 more sources

Antifungal Susceptibility Testing of Dermatophytes

2016
The cases of dermatophytoses have increased over the past few decades. In the last few years, a number of newer less toxic antifungal drugs have become available for clinical use. The increased use of antifungal, often for prolonged periods, has led to the recognition of the phenomenon of acquired antifungal resistance among previously susceptible ...
openaire   +1 more source

Antifungal susceptibility testing and resistance

2018
Abstract The availability of choice of systemically active antifungal agents and the proliferation in the number of fungal species implicated in invasive disease have meant that clinicians are increasingly looking for guidance from clinical laboratory results to help select the most appropriate agent.
openaire   +1 more source